Pitt Street Research | Stock research
Atomo.png

Atomo Diagnostics

Atomo Diagnostics (ASX:AT1) develops unique 'user-friendly' Rapid Diagnostic Tests (RDTs). Atomo’s technology was developed as a test device platform with the initial clinical application focused on HIV/AIDs where the first products were launched in 2018. The company is at a major juncture where it is building a more comprehensive pipeline.

Atomo Diagnostics (ASX:AT1)

 

Atomo Diagnostics (ASX:AT1) develops unique 'user-friendly' Rapid Diagnostic Tests (RDTs). Atomo’s technology was developed as a test device platform with the initial clinical application focused on HIV/AIDs where the first products were launched in 2018. The company is at a major juncture where it is building a more comprehensive pipeline.